Health Care: Drugs

Albany Molecular Research Inc (AMRI: NASDAQ)

$16.67 n/a | n/a%
12/05/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 402.36M 276.57M 246.57M 226.69M
Cost of Sales 259.44M 183.54M 155.52M 150.73M
Gross Operating Profit 142.91M 93.03M 91.05M 75.95M
Selling, General, and Administrative Expenses 77.95M 50.52M 45.02M 44.05M
Research & Development 5.47M 1.00M 414.00K 906.00K
Operating Income before D & A (EBITDA) 59.49M 41.51M 45.62M 31.00M
Depreciation & Amortization 36.08M 25.66M 16.40M 17.33M
Interest Income 14.00K 3.00K 11.00K 9.00K
Other Income - Net 2.22M 1.05M 1.08M -593.00K
Special Income / Charges -3.77M -7.83M -1.86M -8.33M
Total Income Before Interest Expenses (EBIT) 15.88M 5.49M 21.26M 119.00K
Interest Expense 19.35M 10.96M 1.56M 0.00
Pre-Tax Income -3.47M -5.47M 19.70M 119.00K
Income Taxes -1.17M -2.19M 7.93M 4.38M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -2.30M -3.28M 11.77M -4.26M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -2.30M -3.28M 11.77M -4.26M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -2.30M -3.28M 11.77M -4.26M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
7.46M 8.14M 20.81M 8.71M
Preferred Dividends
Net Income Available To Common -2.30M -3.28M 11.77M -4.26M
Basic EPS from Continuing Ops. -0.07 -0.10 0.38 -0.14
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.07 -0.10 0.38 -0.14
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.07 -0.10 0.38 -0.14
Basic Normalized Net Income/Share 0.23 0.25 0.67 0.29
EPS fr Continuing Ops. -0.07 -0.10 0.37 -0.14
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.07 -0.10 0.37 -0.14
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.07 -0.10 0.37 -0.14
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.23 0.25 0.65 0.29
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with AMRI

Latest AMRI Headlines from TheStreet

More Financial News for AMRI

Press Releases for AMRI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter